DK139625C - - Google Patents

Info

Publication number
DK139625C
DK139625C DK217572A DK217572A DK139625C DK 139625 C DK139625 C DK 139625C DK 217572 A DK217572 A DK 217572A DK 217572 A DK217572 A DK 217572A DK 139625 C DK139625 C DK 139625C
Authority
DK
Denmark
Application number
DK217572A
Other languages
Danish (da)
Other versions
DK139625B (da
Inventor
E Schenker
Original Assignee
Sandoz A.G.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH695171A external-priority patent/CH547807A/de
Priority claimed from CH695271A external-priority patent/CH547808A/de
Priority claimed from CH767971A external-priority patent/CH547813A/de
Priority claimed from CH768371A external-priority patent/CH547814A/de
Priority claimed from CH784871A external-priority patent/CH551433A/de
Priority claimed from CH784971A external-priority patent/CH553201A/de
Priority claimed from CH1512171A external-priority patent/CH555841A/de
Priority claimed from CH1512071A external-priority patent/CH555350A/de
Application filed by Sandoz A.G. filed Critical Sandoz A.G.
Publication of DK139625B publication Critical patent/DK139625B/da
Application granted granted Critical
Publication of DK139625C publication Critical patent/DK139625C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK217572AA 1971-05-11 1972-05-02 Analogifremgangsmåde til fremstilling af cycloalkan(c)pyridazin- eller pyrido(4,3-c)pyridazinderivater eller syreadditionssalte deraf. DK139625B (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
CH695171A CH547807A (de) 1971-05-11 1971-05-11 Verfahren zur herstellung neuer cycloalkan(c)pyridazine.
CH695271A CH547808A (de) 1971-05-11 1971-05-11 Verfahren zur herstellung neuer cycloalkan(c)pyridazine.
CH767971A CH547813A (de) 1971-05-26 1971-05-26 Verfahren zur herstellung neuer pyrido (4,3-c)pyridazine.
CH768371A CH547814A (de) 1971-05-26 1971-05-26 Verfahren zur herstellung neuer pyrido (4,3-c)pyridazine.
CH784871A CH551433A (de) 1971-05-26 1971-05-28 Verfahren zur herstellung neuer 3-hydrazino-5,6,7,8-tetrahydropyrido (4,3-c)pyridazin-derivate.
CH784971A CH553201A (de) 1971-05-26 1971-05-28 Verfahren zur herstellung neuer pyrido (4,3-c)pyridazinderivate.
CH1512171A CH555841A (de) 1971-05-26 1971-10-15 Verfahren zur herstellung neuer 3-hydrazinopyrido-(4,3c)pyridazine.
CH1512071A CH555350A (de) 1971-05-26 1971-10-15 Verfahren zur herstellung neuer 3-hydrazinopyrido(4,3c)-pyridazine.

Publications (2)

Publication Number Publication Date
DK139625B DK139625B (da) 1979-03-19
DK139625C true DK139625C (sl) 1979-09-03

Family

ID=27570368

Family Applications (1)

Application Number Title Priority Date Filing Date
DK217572AA DK139625B (da) 1971-05-11 1972-05-02 Analogifremgangsmåde til fremstilling af cycloalkan(c)pyridazin- eller pyrido(4,3-c)pyridazinderivater eller syreadditionssalte deraf.

Country Status (16)

Country Link
US (2) US3838125A (sl)
JP (1) JPS5750791B1 (sl)
AU (1) AU472726B2 (sl)
BE (1) BE783219A (sl)
CA (1) CA943542A (sl)
DD (1) DD97418A5 (sl)
DK (1) DK139625B (sl)
FI (1) FI55343C (sl)
GB (2) GB1392475A (sl)
HU (1) HU168682B (sl)
IE (1) IE36710B1 (sl)
IL (1) IL39392A (sl)
NL (1) NL176565C (sl)
NO (1) NO136251C (sl)
PL (1) PL81827B1 (sl)
SE (1) SE400557B (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO136251C (no) * 1971-05-11 1977-08-10 Sandoz Ag Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater.
FI224574A (sl) * 1973-08-02 1975-02-03 Sandoz Ag
SE418800B (sv) * 1975-11-13 1981-06-29 Sandoz Ag Forfarande for framstellning av nya antihypertensiva preparat
US4277472A (en) * 1978-11-10 1981-07-07 Byk Gulden Lomberg Chemische Fabrik Gmbh 3,6-Disubstituted-5,7-(lower alkano)-5,6,7,8-tetrahydropyrido(4,3-C)pyridazines; their intermediates, preparation, antihypertensive use and compositions
US4473574A (en) * 1982-02-01 1984-09-25 Sandoz Ltd. Prophylaxis of arterial disease
US6705323B1 (en) 1995-06-07 2004-03-16 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US6176240B1 (en) 1995-06-07 2001-01-23 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
US6821974B2 (en) 2002-03-05 2004-11-23 Barbeau Pharma, Inc Stable pharmaceutical compositions
US6825196B2 (en) * 2002-03-05 2004-11-30 Barbeau Pharma, Inc. Stable pharmaceutical compositions
CN102911173A (zh) * 2012-11-08 2013-02-06 苏州施亚生物科技有限公司 5,6,7,8-四氢-2H-吡啶并[4,3-c]哒嗪-3-酮的合成方法
CN106905315B (zh) * 2017-03-02 2019-09-27 北京工业大学 四氢吡啶并[3,4-d]嘧啶类化合物及其制备方法和应用
CN112292758B (zh) 2018-07-10 2024-07-12 国立研究开发法人产业技术综合研究所 积层构造体及积层构造体的制造方法以及半导体装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO136251C (no) * 1971-05-11 1977-08-10 Sandoz Ag Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater.

Also Published As

Publication number Publication date
FI55343C (fi) 1979-07-10
US3838125A (en) 1974-09-24
FI55343B (fi) 1979-03-30
HU168682B (sl) 1976-06-28
IE36710B1 (en) 1977-02-02
SE400557B (sv) 1978-04-03
DD97418A5 (sl) 1973-05-05
NL176565C (nl) 1985-05-01
PL81827B1 (sl) 1975-10-31
JPS5750791B1 (sl) 1982-10-28
NO136251B (sl) 1977-05-02
AU472726B2 (en) 1976-06-03
BE783219A (fr) 1972-11-09
DK139625B (da) 1979-03-19
IL39392A0 (en) 1972-07-26
IE36710L (en) 1972-11-11
AU4213572A (en) 1973-11-15
NL7206477A (sl) 1972-11-14
US4478837A (en) 1984-10-23
NO136251C (no) 1977-08-10
GB1392474A (en) 1975-04-30
GB1392475A (en) 1975-04-30
IL39392A (en) 1977-10-31
CA943542A (en) 1974-03-12
NL176565B (nl) 1984-12-03

Similar Documents

Publication Publication Date Title
DK139625C (sl)
ATA136472A (sl)
AR196074A1 (sl)
AU2894671A (sl)
AU2485671A (sl)
AU2941471A (sl)
AU2952271A (sl)
AU3005371A (sl)
AU2938071A (sl)
AU1109576A (sl)
AU2880771A (sl)
AU2885171A (sl)
AU2654071A (sl)
AR202997Q (sl)
AU2907471A (sl)
AU3025871A (sl)
AR192311Q (sl)
AU2486471A (sl)
AU2927871A (sl)
AU2455871A (sl)
AU2930871A (sl)
AU2399971A (sl)
AU2473671A (sl)
AU5395373A (sl)
AU3038671A (sl)

Legal Events

Date Code Title Description
PBP Patent lapsed